IBX 2.50% 3.9¢ imagion biosystems limited

Ann: First-in-human study update - First patient enrolled, page-411

  1. 43 Posts.
    lightbulb Created with Sketch. 3
    Cant see why anyone would be getting their wrist slapped for giving out that kind of information about the trial. If anything they should be given a gold star for promoting the study. What better way to promote it? And sayingthere are already 4 patients enrolled ( without any adverse reactions???) Could be the enticement needed to get people over the line
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.